Annual FCF
-$2.42 M
+$4.01 M+62.39%
March 31, 2024
Summary
- As of February 7, 2025, SNOA annual free cash flow is -$2.42 million, with the most recent change of +$4.01 million (+62.39%) on March 31, 2024.
- During the last 3 years, SNOA annual FCF has risen by +$1.14 million (+32.11%).
- SNOA annual FCF is now -370.44% below its all-time high of $893.00 thousand, reached on March 31, 2013.
Performance
SNOA Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
$563.00 K
+$235.00 K+71.65%
December 31, 2024
Summary
- As of February 7, 2025, SNOA quarterly free cash flow is $563.00 thousand, with the most recent change of +$235.00 thousand (+71.65%) on December 31, 2024.
- Over the past year, SNOA quarterly FCF has increased by +$1.67 million (+150.95%).
- SNOA quarterly FCF is now -87.48% below its all-time high of $4.50 million, reached on September 30, 2012.
Performance
SNOA Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
$129.00 K
+$1.67 M+108.38%
December 31, 2024
Summary
- As of February 7, 2025, SNOA TTM free cash flow is $129.00 thousand, with the most recent change of +$1.67 million (+108.38%) on December 31, 2024.
- Over the past year, SNOA TTM FCF has increased by +$5.33 million (+102.48%).
- SNOA TTM FCF is now -85.92% below its all-time high of $916.00 thousand, reached on June 30, 2013.
Performance
SNOA TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
SNOA Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +62.4% | +150.9% | +102.5% |
| 3 y3 years | +32.1% | +121.4% | +102.0% |
| 5 y5 years | +79.6% | +121.4% | +102.0% |
SNOA Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +62.4% | at high | +121.4% | at high | +102.0% |
| 5 y | 5-year | at high | +79.6% | -15.8% | +115.2% | at high | +101.6% |
| alltime | all time | -370.4% | +88.5% | -87.5% | +108.1% | -85.9% | +100.7% |
Sonoma Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | - | $563.00 K(+71.6%) | $129.00 K(-108.4%) |
| Sep 2024 | - | $328.00 K(-135.8%) | -$1.54 M(-50.4%) |
| Jun 2024 | - | -$917.00 K(-691.6%) | -$3.10 M(+28.4%) |
| Mar 2024 | -$2.42 M(-62.4%) | $155.00 K(-114.0%) | -$2.42 M(-53.6%) |
| Dec 2023 | - | -$1.10 M(-10.4%) | -$5.20 M(+16.2%) |
| Sep 2023 | - | -$1.23 M(+431.5%) | -$4.47 M(-12.2%) |
| Jun 2023 | - | -$232.00 K(-91.2%) | -$5.10 M(-20.6%) |
| Mar 2023 | -$6.42 M(+46.4%) | -$2.63 M(+594.2%) | -$6.42 M(+22.4%) |
| Dec 2022 | - | -$379.00 K(-79.6%) | -$5.25 M(+1.0%) |
| Sep 2022 | - | -$1.85 M(+19.2%) | -$5.20 M(+11.3%) |
| Jun 2022 | - | -$1.56 M(+6.8%) | -$4.67 M(+6.5%) |
| Mar 2022 | -$4.38 M(+23.3%) | -$1.46 M(+345.6%) | -$4.38 M(-0.5%) |
| Dec 2021 | - | -$327.00 K(-75.4%) | -$4.41 M(+29.2%) |
| Sep 2021 | - | -$1.33 M(+4.5%) | -$3.41 M(+37.3%) |
| Jun 2021 | - | -$1.27 M(-14.1%) | -$2.49 M(-30.1%) |
| Mar 2021 | -$3.56 M(-25.8%) | -$1.48 M(-321.4%) | -$3.56 M(-38.5%) |
| Dec 2020 | - | $669.00 K(-266.4%) | -$5.79 M(-20.8%) |
| Sep 2020 | - | -$402.00 K(-82.8%) | -$7.30 M(-7.1%) |
| Jun 2020 | - | -$2.34 M(-36.9%) | -$7.87 M(+64.0%) |
| Mar 2020 | -$4.80 M(-59.4%) | -$3.71 M(+337.1%) | -$4.80 M(+24.7%) |
| Dec 2019 | - | -$849.00 K(-11.8%) | -$3.85 M(-28.6%) |
| Sep 2019 | - | -$963.00 K(-232.6%) | -$5.39 M(-32.7%) |
| Jun 2019 | - | $726.00 K(-126.3%) | -$8.00 M(-32.3%) |
| Mar 2019 | -$11.82 M(-6.4%) | -$2.76 M(+15.3%) | -$11.82 M(-2.5%) |
| Dec 2018 | - | -$2.39 M(-33.1%) | -$12.11 M(+1.8%) |
| Sep 2018 | - | -$3.58 M(+15.9%) | -$11.89 M(+8.9%) |
| Jun 2018 | - | -$3.09 M(+1.0%) | -$10.92 M(-13.5%) |
| Mar 2018 | -$12.63 M(+47.5%) | -$3.06 M(+40.6%) | -$12.63 M(+1.3%) |
| Dec 2017 | - | -$2.17 M(-16.5%) | -$12.46 M(+4.8%) |
| Sep 2017 | - | -$2.60 M(-45.6%) | -$11.89 M(+8.5%) |
| Jun 2017 | - | -$4.79 M(+65.5%) | -$10.96 M(+28.0%) |
| Mar 2017 | -$8.56 M(-5.8%) | -$2.89 M(+80.6%) | -$8.56 M(+16.0%) |
| Dec 2016 | - | -$1.60 M(-4.3%) | -$7.38 M(-14.1%) |
| Sep 2016 | - | -$1.67 M(-30.0%) | -$8.59 M(-1.8%) |
| Jun 2016 | - | -$2.39 M(+39.5%) | -$8.75 M(-3.8%) |
| Mar 2016 | -$9.09 M | -$1.71 M(-39.1%) | -$9.09 M(-9.7%) |
| Dec 2015 | - | -$2.81 M(+53.9%) | -$10.06 M(+20.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2015 | - | -$1.83 M(-33.1%) | -$8.37 M(+2.1%) |
| Jun 2015 | - | -$2.73 M(+1.7%) | -$8.20 M(+20.0%) |
| Mar 2015 | -$6.83 M(+26.7%) | -$2.69 M(+140.0%) | -$6.83 M(+20.6%) |
| Dec 2014 | - | -$1.12 M(-32.4%) | -$5.67 M(+0.7%) |
| Sep 2014 | - | -$1.66 M(+21.3%) | -$5.63 M(+2.0%) |
| Jun 2014 | - | -$1.37 M(-10.2%) | -$5.52 M(+2.3%) |
| Mar 2014 | -$5.39 M(-704.0%) | -$1.52 M(+41.1%) | -$5.39 M(+6.9%) |
| Dec 2013 | - | -$1.08 M(-30.3%) | -$5.04 M(-1.7%) |
| Sep 2013 | - | -$1.55 M(+24.6%) | -$5.13 M(-659.9%) |
| Jun 2013 | - | -$1.24 M(+6.0%) | $916.00 K(+2.6%) |
| Mar 2013 | $893.00 K(-120.4%) | -$1.17 M(+0.8%) | $893.00 K(+80.8%) |
| Dec 2012 | - | -$1.16 M(-125.9%) | $494.00 K(+14.4%) |
| Sep 2012 | - | $4.50 M(-455.1%) | $432.00 K(-108.6%) |
| Jun 2012 | - | -$1.27 M(-19.5%) | -$5.04 M(+15.5%) |
| Mar 2012 | -$4.37 M(-5.1%) | -$1.57 M(+28.2%) | -$4.37 M(+47.0%) |
| Dec 2011 | - | -$1.23 M(+25.2%) | -$2.97 M(-12.3%) |
| Sep 2011 | - | -$979.00 K(+65.7%) | -$3.39 M(-8.0%) |
| Jun 2011 | - | -$591.00 K(+237.7%) | -$3.68 M(-20.0%) |
| Mar 2011 | -$4.60 M(-32.1%) | -$175.00 K(-89.3%) | -$4.60 M(-23.7%) |
| Dec 2010 | - | -$1.64 M(+29.1%) | -$6.03 M(-1.8%) |
| Sep 2010 | - | -$1.27 M(-15.8%) | -$6.14 M(-6.7%) |
| Jun 2010 | - | -$1.51 M(-5.8%) | -$6.58 M(-2.9%) |
| Mar 2010 | -$6.78 M(-60.6%) | -$1.60 M(-8.4%) | -$6.78 M(-9.1%) |
| Dec 2009 | - | -$1.75 M(+2.2%) | -$7.46 M(-14.3%) |
| Sep 2009 | - | -$1.71 M(+0.3%) | -$8.71 M(-27.3%) |
| Jun 2009 | - | -$1.71 M(-25.2%) | -$11.98 M(-30.4%) |
| Mar 2009 | -$17.23 M(-4.6%) | -$2.29 M(-23.7%) | -$17.23 M(-7.4%) |
| Dec 2008 | - | -$3.00 M(-39.9%) | -$18.60 M(-6.4%) |
| Sep 2008 | - | -$4.99 M(-28.2%) | -$19.87 M(+2.3%) |
| Jun 2008 | - | -$6.95 M(+89.9%) | -$19.42 M(+7.5%) |
| Mar 2008 | -$18.06 M(-4.7%) | -$3.66 M(-14.3%) | -$18.06 M(+25.4%) |
| Dec 2007 | - | -$4.27 M(-5.9%) | -$14.40 M(+42.2%) |
| Sep 2007 | - | -$4.54 M(-18.8%) | -$10.13 M(+81.2%) |
| Jun 2007 | - | -$5.59 M | -$5.59 M |
| Mar 2007 | -$18.95 M(-9.7%) | - | - |
| Mar 2006 | -$21.00 M(+44.0%) | - | - |
| Mar 2005 | -$14.57 M | - | - |
FAQ
- What is Sonoma Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Sonoma Pharmaceuticals?
- What is Sonoma Pharmaceuticals annual FCF year-on-year change?
- What is Sonoma Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Sonoma Pharmaceuticals?
- What is Sonoma Pharmaceuticals quarterly FCF year-on-year change?
- What is Sonoma Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Sonoma Pharmaceuticals?
- What is Sonoma Pharmaceuticals TTM FCF year-on-year change?
What is Sonoma Pharmaceuticals annual free cash flow?
The current annual FCF of SNOA is -$2.42 M
What is the all time high annual FCF for Sonoma Pharmaceuticals?
Sonoma Pharmaceuticals all-time high annual free cash flow is $893.00 K
What is Sonoma Pharmaceuticals annual FCF year-on-year change?
Over the past year, SNOA annual free cash flow has changed by +$4.01 M (+62.39%)
What is Sonoma Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of SNOA is $563.00 K
What is the all time high quarterly FCF for Sonoma Pharmaceuticals?
Sonoma Pharmaceuticals all-time high quarterly free cash flow is $4.50 M
What is Sonoma Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, SNOA quarterly free cash flow has changed by +$1.67 M (+150.95%)
What is Sonoma Pharmaceuticals TTM free cash flow?
The current TTM FCF of SNOA is $129.00 K
What is the all time high TTM FCF for Sonoma Pharmaceuticals?
Sonoma Pharmaceuticals all-time high TTM free cash flow is $916.00 K
What is Sonoma Pharmaceuticals TTM FCF year-on-year change?
Over the past year, SNOA TTM free cash flow has changed by +$5.33 M (+102.48%)